BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12734399)

  • 1. NF-kappaB signalling is inhibited by glucocorticoid receptor and STAT6 via distinct mechanisms.
    Nelson G; Wilde GJ; Spiller DG; Kennedy SM; Ray DW; Sullivan E; Unitt JF; White MR
    J Cell Sci; 2003 Jun; 116(Pt 12):2495-503. PubMed ID: 12734399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic analysis of STAT6 signalling in living cells.
    Nelson G; Wilde GJ; Spiller DG; Sullivan E; Unitt JF; White MR
    FEBS Lett; 2002 Dec; 532(1-2):188-92. PubMed ID: 12459487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BZLF1, an Epstein-Barr virus immediate-early protein, induces p65 nuclear translocation while inhibiting p65 transcriptional function.
    Morrison TE; Kenney SC
    Virology; 2004 Oct; 328(2):219-32. PubMed ID: 15464842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-4 abrogates osteoclastogenesis through STAT6-dependent inhibition of NF-kappaB.
    Abu-Amer Y
    J Clin Invest; 2001 Jun; 107(11):1375-85. PubMed ID: 11390419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CBP (CREB binding protein) integrates NF-kappaB (nuclear factor-kappaB) and glucocorticoid receptor physical interactions and antagonism.
    McKay LI; Cidlowski JA
    Mol Endocrinol; 2000 Aug; 14(8):1222-34. PubMed ID: 10935546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HIV-1 Vpr and glucocorticoid receptor complex is a gain-of-function interaction that prevents the nuclear localization of PARP-1.
    Muthumani K; Choo AY; Zong WX; Madesh M; Hwang DS; Premkumar A; Thieu KP; Emmanuel J; Kumar S; Thompson CB; Weiner DB
    Nat Cell Biol; 2006 Feb; 8(2):170-9. PubMed ID: 16429131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of mitochondrial thioredoxin with glucocorticoid receptor and NF-kappaB modulates glucocorticoid receptor and NF-kappaB signalling in HEK-293 cells.
    Psarra AM; Hermann S; Panayotou G; Spyrou G
    Biochem J; 2009 Aug; 422(3):521-31. PubMed ID: 19570036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors.
    Scheinman RI; Gualberto A; Jewell CM; Cidlowski JA; Baldwin AS
    Mol Cell Biol; 1995 Feb; 15(2):943-53. PubMed ID: 7823959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-parameter analysis of the kinetics of NF-kappaB signalling and transcription in single living cells.
    Nelson G; Paraoan L; Spiller DG; Wilde GJ; Browne MA; Djali PK; Unitt JF; Sullivan E; Floettmann E; White MR
    J Cell Sci; 2002 Mar; 115(Pt 6):1137-48. PubMed ID: 11884514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of selected natural compounds with anti-inflammatory activity on the glucocorticoid receptor and NF-kappaB in HeLa cells.
    Dvorák Z; Vrzal R; Maurel P; Ulrichová J
    Chem Biol Interact; 2006 Feb; 159(2):117-28. PubMed ID: 16289013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inhibition of LPS-induced production of inflammatory cytokines by HSP70 involves inactivation of the NF-kappaB pathway but not the MAPK pathways.
    Shi Y; Tu Z; Tang D; Zhang H; Liu M; Wang K; Calderwood SK; Xiao X
    Shock; 2006 Sep; 26(3):277-84. PubMed ID: 16912653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid receptor and nuclear factor-kappa B interactions in restraint stress-mediated protection against acoustic trauma.
    Tahera Y; Meltser I; Johansson P; Hansson AC; Canlon B
    Endocrinology; 2006 Sep; 147(9):4430-7. PubMed ID: 16777974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytosolic glucocorticoid receptor interaction with nuclear factor-kappa B proteins in rat liver cells.
    Widén C; Gustafsson JA; Wikström AC
    Biochem J; 2003 Jul; 373(Pt 1):211-20. PubMed ID: 12672265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone prevents interleukin-1beta-induced nuclear factor-kappaB activation by upregulating IkappaB-alpha synthesis, in lymphoblastic cells.
    Castro-Caldas M; Mendes AF; Carvalho AP; Duarte CB; Lopes MC
    Mediators Inflamm; 2003 Feb; 12(1):37-46. PubMed ID: 12745547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of glucocorticoid receptor translocation, cytoplasmic IkappaB, nuclear NFkappaB, and activation of NFkappaB in T lymphocytes exposed to stress-inducible concentrations of corticosterone in vivo.
    Pruett SB; Fan R; Zheng Q
    Int Immunopharmacol; 2003 Jan; 3(1):1-16. PubMed ID: 12538030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of NF-kappa B, AP-1, NFAT, and STAT1 nuclear import in T lymphocytes by noninvasive delivery of peptide carrying the nuclear localization sequence of NF-kappa B p50.
    Torgerson TR; Colosia AD; Donahue JP; Lin YZ; Hawiger J
    J Immunol; 1998 Dec; 161(11):6084-92. PubMed ID: 9834092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic inhibits NF-kappaB-mediated gene transcription by blocking IkappaB kinase activity and IkappaBalpha phosphorylation and degradation.
    Roussel RR; Barchowsky A
    Arch Biochem Biophys; 2000 May; 377(1):204-12. PubMed ID: 10775461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of stat6 and NF-kappaB: direct association and synergistic activation of interleukin-4-induced transcription.
    Shen CH; Stavnezer J
    Mol Cell Biol; 1998 Jun; 18(6):3395-404. PubMed ID: 9584180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of chroman carboxamide on interleukin-6 expression in response to lipopolysaccharide by preventing nuclear factor-kappaB activation in macrophages.
    Kim BH; Lee KH; Chung EY; Chang YS; Lee H; Lee CK; Min KR; Kim Y
    Eur J Pharmacol; 2006 Aug; 543(1-3):158-65. PubMed ID: 16797005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential mechanism of NF-kappaB inhibition by two glucocorticoid receptor modulators in rheumatoid arthritis synovial fibroblasts.
    Gossye V; Elewaut D; Bougarne N; Bracke D; Van Calenbergh S; Haegeman G; De Bosscher K
    Arthritis Rheum; 2009 Nov; 60(11):3241-50. PubMed ID: 19877072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.